Literature DB >> 21393328

An apparently silent nucleotide substitution (c.7056C>T) in the von Willebrand factor gene is responsible for type 1 von Willebrand disease.

Viviana Daidone1, Lisa Gallinaro, Maria Grazia Cattini, Elena Pontara, Antonella Bertomoro, Antonio Pagnan, Alessandra Casonato.   

Abstract

BACKGROUND: Nucleotide variations not changing protein sequences are considered silent mutations; accumulating data suggest that they can, however, be important in human diseases. DESIGN AND METHODS: We report an altered splicing process induced by a silent substitution (c.7056C>T) in the von Willebrand factor gene in a case of type 1 von Willebrand disease originally classified as lacking von Willebrand factor mutations.
RESULTS: The c.7056C>T synonymous substitution introduces a new donor splice site within exon 41, leading to messenger RNA lacking nucleotides 7055-7081 (c.7055_7081del). The encoded von Willebrand factor protein is predicted to lack amino acids 2352-2360 in the B2 domain. The patient's von Willebrand disease phenotype was characterized by reduced plasma and platelet von Willebrand factor, which was normal in function and multimer structure. In vitro expression studies demonstrated that co-transfection of equimolar c.7055_7081del and wild-type von Willebrand factor (mimicking the patient's heterozygous state) induced a 50% lower von Willebrand factor secretion than the wild type, while almost no von Willebrand factor secretion was seen with the mutated von Willebrand factor alone. The secreted von Willebrand factor was structurally and functionally normal, suggesting that the c.7056C>T substitution behaves like a loss-of-function allele.
CONCLUSIONS: This is the first report of a synonymous von Willebrand factor substitution being responsible for von Willebrand disease. Our findings suggest the need to reconsider the role of von Willebrand factor polymorphisms in von Willebrand disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21393328      PMCID: PMC3105650          DOI: 10.3324/haematol.2010.036848

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  37 in total

1.  Haemostasis in normal pregnancy.

Authors:  Y Stirling; L Woolf; W R North; M J Seghatchian; T W Meade
Journal:  Thromb Haemost       Date:  1984-10-31       Impact factor: 5.249

2.  The dominant-negative von Willebrand factor gene deletion p.P1127_C1948delinsR: molecular mechanism and modulation.

Authors:  Caterina Casari; Mirko Pinotti; Stefano Lancellotti; Elena Adinolfi; Alessandra Casonato; Raimondo De Cristofaro; Francesco Bernardi
Journal:  Blood       Date:  2010-08-27       Impact factor: 22.113

3.  Significant linkage and non-linkage of type 1 von Willebrand disease to the von Willebrand factor gene.

Authors:  P Casaña; F Martínez; S Haya; C Espinós; J A Aznar
Journal:  Br J Haematol       Date:  2001-12       Impact factor: 6.998

4.  A standard nomenclature for von Willebrand factor gene mutations and polymorphisms. On behalf of the ISTH SSC Subcommittee on von Willebrand factor.

Authors:  A C Goodeve; J C Eikenboom; D Ginsburg; L Hilbert; C Mazurier; I R Peake; J E Sadler; F Rodeghiero
Journal:  Thromb Haemost       Date:  2001-05       Impact factor: 5.249

5.  Type 1 von Willebrand disease due to reduced von Willebrand factor synthesis and/or survival: observations from a case series.

Authors:  Alessandra Casonato; Lisa Gallinaro; Maria Grazia Cattini; Francesca Sartorello; Elena Pontara; Roberto Padrini; Antonella Bertomoro; Viviana Daidone; Antonio Pagnan
Journal:  Transl Res       Date:  2009-12-30       Impact factor: 7.012

Review 6.  Von Willebrand factor.

Authors:  Zaverio M Ruggeri
Journal:  Curr Opin Hematol       Date:  2003-03       Impact factor: 3.284

7.  Modifiers of von Willebrand factor identified by natural variation in inbred strains of mice.

Authors:  Jordan A Shavit; Ani Manichaikul; Heidi L Lemmerhirt; Karl W Broman; David Ginsburg
Journal:  Blood       Date:  2009-09-29       Impact factor: 22.113

8.  Synthesis of von Willebrand factor by cultured human endothelial cells.

Authors:  E A Jaffe; L W Hoyer; R L Nachman
Journal:  Proc Natl Acad Sci U S A       Date:  1974-05       Impact factor: 11.205

9.  An Arg760Cys mutation in the consensus sequence of the von Willebrand factor propeptide cleavage site is responsible for a new von Willebrand disease variant.

Authors:  Alessandra Casonato; Francesca Sartorello; Maria Grazia Cattini; Elena Pontara; Carmen Soldera; Antonella Bertomoro; Antonio Girolami
Journal:  Blood       Date:  2002-08-08       Impact factor: 22.113

10.  Reduced von Willebrand factor survival in type Vicenza von Willebrand disease.

Authors:  Alessandra Casonato; Elena Pontara; Francesca Sartorello; Maria Grazia Cattini; Maria Teresa Sartori; Roberto Padrini; Antonio Girolami
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

View more
  11 in total

1.  The molecular basis of von Willebrand disease: the under investigated, the unexpected and the overlooked.

Authors:  Daniel J Hampshire; Anne C Goodeve
Journal:  Haematologica       Date:  2011-06       Impact factor: 9.941

2.  A common ancestor more than 10,000 years old for patients with R854Q-related type 2N von Willebrand's disease in Italy.

Authors:  Alessandra Casonato; Viviana Daidone; Giovanni Barbon; Elena Pontara; Irene Di Pasquale; Lisa Gallinaro; Letizia Marullo; Giorgio Bertorelle
Journal:  Haematologica       Date:  2012-08-08       Impact factor: 9.941

3.  Synonymous codon substitutions perturb cotranslational protein folding in vivo and impair cell fitness.

Authors:  Ian M Walsh; Micayla A Bowman; Iker F Soto Santarriaga; Anabel Rodriguez; Patricia L Clark
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-03       Impact factor: 11.205

4.  Variable content of von Willebrand factor mutant monomer drives the phenotypic variability in a family with von Willebrand disease.

Authors:  Junmei Chen; Jesse D Hinckley; Sandra Haberichter; Paula Jacobi; Robert Montgomery; Veronica H Flood; Randall Wong; Gianluca Interlandi; Dominic W Chung; José A López; Jorge Di Paola
Journal:  Blood       Date:  2015-05-27       Impact factor: 22.113

5.  Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders.

Authors:  Kate Downes; Karyn Megy; Daniel Duarte; Minka Vries; Johanna Gebhart; Stefanie Hofer; Olga Shamardina; Sri V V Deevi; Jonathan Stephens; Rutendo Mapeta; Salih Tuna; Namir Al Hasso; Martin W Besser; Nichola Cooper; Louise Daugherty; Nick Gleadall; Daniel Greene; Matthias Haimel; Howard Martin; Sofia Papadia; Shoshana Revel-Vilk; Suthesh Sivapalaratnam; Emily Symington; Will Thomas; Chantal Thys; Alexander Tolios; Christopher J Penkett; Willem H Ouwehand; Stephen Abbs; Michael A Laffan; Ernest Turro; Ilenia Simeoni; Andrew D Mumford; Yvonne M C Henskens; Ingrid Pabinger; Keith Gomez; Kathleen Freson
Journal:  Blood       Date:  2019-12-05       Impact factor: 22.113

6.  Identification of von Willebrand factor D4 domain mutations in patients of Afro-Caribbean descent: In vitro characterization.

Authors:  Marie-Daniéla Dubois; Ivan Peyron; Olivier-Nicolas Pierre-Louis; Serge Pierre-Louis; Johalène Rabout; Pierre Boisseau; Annika de Jong; Sophie Susen; Jenny Goudemand; Rémi Neviere; Pascal Fuseau; Olivier D Christophe; Peter J Lenting; Cécile V Denis; Caterina Casari
Journal:  Res Pract Thromb Haemost       Date:  2022-06-15

7.  von Willebrand disease and von Willebrand factor.

Authors:  Brooke Sadler; Giancarlo Castaman; James S O'Donnell
Journal:  Haemophilia       Date:  2022-05       Impact factor: 4.263

8.  Identification and functional analysis of a novel von Willebrand factor mutation in a family with type 2A von Willebrand disease.

Authors:  Jing Dong; Xiaojuan Zhao; Sensen Shi; Zhenni Ma; Meng Liu; Qingyu Wu; Changgeng Ruan; Ningzheng Dong
Journal:  PLoS One       Date:  2012-03-27       Impact factor: 3.240

9.  The Impact of Selection at the Amino Acid Level on the Usage of Synonymous Codons.

Authors:  Paweł Błażej; Dorota Mackiewicz; Małgorzata Wnętrzak; Paweł Mackiewicz
Journal:  G3 (Bethesda)       Date:  2017-03-10       Impact factor: 3.154

10.  Unraveling the effect of silent, intronic and missense mutations on VWF splicing: contribution of next generation sequencing in the study of mRNA.

Authors:  Nina Borràs; Gerard Orriols; Javier Batlle; Almudena Pérez-Rodríguez; Teresa Fidalgo; Patricia Martinho; María Fernanda López-Fernández; Ángela Rodríguez-Trillo; Esther Lourés; Rafael Parra; Carme Altisent; Ana Rosa Cid; Santiago Bonanad; Noelia Cabrera; Andrés Moret; María Eva Mingot-Castellano; Nira Navarro; Rocío Pérez-Montes; Sally Marcellin; Ana Moreto; Sonia Herrero; Inmaculada Soto; Núria Fernández-Mosteirín; Víctor Jiménez-Yuste; Nieves Alonso; Aurora de Andrés-Jacob; Emilia Fontanes; Rosa Campos; María José Paloma; Nuria Bermejo; Ruben Berrueco; José Mateo; Karmele Arribalzaga; Pascual Marco; Ángeles Palomo; Nerea Castro Quismondo; Belén Iñigo; María Del Mar Nieto; Rosa Vidal; María Paz Martínez; Reyes Aguinaco; Jesús María Tenorio; María Ferreiro; Javier García-Frade; Ana María Rodríguez-Huerta; Jorge Cuesta; Ramón Rodríguez-González; Faustino García-Candel; Manuela Dobón; Carlos Aguilar; Francisco Vidal; Irene Corrales
Journal:  Haematologica       Date:  2018-10-25       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.